Cite
HARVARD Citation
Fouladi, M. et al. (n.d.). A phase I trial of MK‐2206 in children with refractory malignancies: A Children's Oncology Group study. Pediatric blood & cancer. 61 (7), pp. 1246-1251. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fouladi, M. et al. (n.d.). A phase I trial of MK‐2206 in children with refractory malignancies: A Children's Oncology Group study. Pediatric blood & cancer. 61 (7), pp. 1246-1251. [Online].